NI-57 is a potent and selective inhibitor of the bromodomain and plant homeodomain finger-containing (BRPF) protein family, with IC50 values of 3.1 nM, 46 nM, and 140 nM for BRPF1, BRPF2 (BRD1), and BRPF3, respectively; it exhibits weaker activity against BRD9 (IC50 = 520 nM), BRD4(BD1) (IC50 = 3700 nM), and TRIM24 (IC50 = 1600 nM); NI-57 inhibits BRPF bromodomains in the nucleus and reduces CCL-22 gene expression by 27.7 ± 9.4% upon BRPF1 inhibition at 10 μM; it demonstrates favorable oral bioavailability in mice.